A Radiation Oncologist's and Thoracic Surgeon's View on the Role of Stereotactic Ablative Radiotherapy for Operable Lung Cancer

Robert D. Timmerman, Hiran C. Fernando

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Abstract

Stereotactic ablative radiotherapy, also known as stereotactic body radiation therapy, has been developed as an innovative therapy for stage I non-small cell lung cancer and has now emerged as a standard treatment option for medically inoperable patients through careful analysis using prospective multi-institutional trials. We review and update the evidence for use of stereotactic ablative radiotherapy in medically inoperable patients with stage I lung cancer, and its possible extension of use to operable patients, from the perspectives of an experienced radiation oncologist and a thoracic surgeon.

Original languageEnglish (US)
Pages (from-to)8-13
Number of pages6
JournalSeminars in thoracic and cardiovascular surgery
Volume25
Issue number1
DOIs
StatePublished - Jul 4 2013

Keywords

  • Early stage
  • Non-small cell lung cancer
  • Operable
  • SABR
  • SBRT
  • Stereotactic ablative radiotherapy

ASJC Scopus subject areas

  • Surgery
  • Pulmonary and Respiratory Medicine
  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'A Radiation Oncologist's and Thoracic Surgeon's View on the Role of Stereotactic Ablative Radiotherapy for Operable Lung Cancer'. Together they form a unique fingerprint.

Cite this